Myeloid malignancies (MMs) are a heterogeneous group of haematological malignancies presenting different incidence, prognosis and survival. Changing classifications (French-American-British (FAB), World Health Organization (WHO) 2001 and WHO 2008) and few population-based published studies available in the literature, complicate international comparative epidemiological studies. This is the reason why the population-based Girona Cancer Registry exhaustively evaluates the actual status of MMs diagnosed in our province analysing a fifteen years period, with the aim to increasing the existing data related with incidence and survival of these infrequent pathologies
© 2001-2024 Fundación Dialnet · Todos los derechos reservados